The safety, immunogenicity, and acceptability of inactivated influenza vaccine delivered by microneedle patch (TIV-MNP 2015): a randomised, partly blinded, placebo-controlled, phase 1 trial. (Q40151720)
Jump to navigation
Jump to search
scientific article published on 27 June 2017
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The safety, immunogenicity, and acceptability of inactivated influenza vaccine delivered by microneedle patch (TIV-MNP 2015): a randomised, partly blinded, placebo-controlled, phase 1 trial. |
scientific article published on 27 June 2017 |
Statements
The safety, immunogenicity, and acceptability of inactivated influenza vaccine delivered by microneedle patch (TIV-MNP 2015): a randomised, partly blinded, placebo-controlled, phase 1 trial (English)
Paula M Frew
Nadine G Rouphael
Michele Paine
Regina Mosley
Sebastien Henry
Devin V McAllister
Haripriya Kalluri
Winston Pewin
Tianwei Yu
Sarah Kabbani
Elena V Vassilieva
Ioanna Skountzou
Richard W Compans
TIV-MNP 2015 Study Group